MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading provider of high-quality, long-read sequencing technologies, today announced a collaboration with iHope, a global rare ...

Please note that today's event is being recorded. I would now like to turn the conference over to Kelly Gerra with Investor Relations. Please go ahead. Good afternoon, and welcome to PacBio's Fourth ...

Carrie Mendivil: Good afternoon, and welcome to Pacific Biosciences of California, Inc.'s Fourth Quarter and Full Year 2025 Earnings Conference Call. Earlier today, we issued a press release outlining ...

Gross margin, operating expenses, net income (loss), and net income (loss) per share are reported on a GAAP and non-GAAP basis. The non-GAAP measures are described below and reconciled to the ...

Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.2 per share a year ago.

MENLO PARK, Calif. (AP) — MENLO PARK, Calif. (AP) — Pacific Biosciences of California Inc. (PACB) on Thursday reported a loss of $40.4 million in its fourth quarter. On a per-share basis, the Menlo ...

The latest update is out from Pacific Biosciences ( (PACB)). On January 30, 2026, Pacific Biosciences of California completed the sale of certain intellectual property and other assets tied to its ...

Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q4 CY2025 results , with sales up 13.8% year on year to $44.65 million. Its non-GAAP loss of $0.12 per share was 10.8% above ...

Analysts covering Pacific Biosciences of California have kept their fair value anchor essentially steady at about US$2.42 per share, while making small tweaks to the assumptions that support that ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...